News
Videos
Conferences
Events
Resources
Subscribe

News|Videos|April 20, 2016

Clinical Trials and Stem Cell Transplants

Episodes in this series

EP. 1 Types of Multiple Myeloma

EP. 1 Types of Multiple Myeloma

EP. 2 Testing Procedures and Considerations

EP. 2 Testing Procedures and Considerations

EP. 3 Considerations For Treatment

EP. 3 Considerations For Treatment

EP. 4 Monitoring Patients

EP. 4 Monitoring Patients

EP. 5 Top Considerations for Maintenance Therapy

EP. 5 Top Considerations for Maintenance Therapy

EP. 6 New Drug Classes For Treatment

EP. 6 New Drug Classes For Treatment

EP. 7 Clinical Trials and Stem Cell Transplants

EP. 7 Clinical Trials and Stem Cell Transplants

EP. 8 Professional Expectations for Future

EP. 8 Professional Expectations for Future

Newsletter

Stay up to date on cancer updates, research and education

Related Content

Image of Tracy.

Managing Nutrition Changes in Patients With Gastrointestinal Cancers

ByDr. Tracy Proverb-Sign

January 28th 2026

Image of Kim.

Grieving After Cancer: Advice for Those Grieving and Supporting Them

January 28th 2026

A phase 2 trial showed onvansertib plus FOLFIRI and Avastin improved response and disease control in first-line RAS-mutated metastatic colorectal cancer: © stock.adobe.com.

Onvansertib Combo Improves Outcomes in First-Line RAS-Mutated mCRC

January 28th 2026

FDA

FDA Grants Orphan Drug Status to CTD402 for Rare T-Cell Blood Cancers

January 28th 2026

The NCCN Clinical Practice Guidelines in Oncology now include Besremi as a Category 1 preferred treatment option for some with high-risk essential thrombocythemia: © stock.adobe.com.

Besremi Recognized by Updated Guidelines for Essential Thrombocythemia

January 28th 2026

Trending on CURE

FDA Approves Darzalex Faspro-VRd For Newly Diagnosed, Transplant Ineligible Multiple Myeloma

Beyond Statistics: Lessons in Mindset and Action from a Cancer Survivor

Cancer and Answering the Phone

Breast Cancer Surgeon and Survivor Undergoes Nerve-Sparing Procedure

FDA Grants Designation to Bezuclastinib Combo in Advanced GIST